← All trials
NCT05670730
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 9, 2022
- Primary completion
- Mar 31, 2025
- Completion date
- Mar 31, 2025
- First posted
- Jan 4, 2023
- Last posted
- Sep 28, 2023
- Enrollment
- 64
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Avidity Biosciences, Inc.Lead sponsor
- Avidity Biosciences, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.